Home Applications Markets Overview Health Food Energy Environment Technology Company Overview Management Team Board of Directors Newsroom Careers IIBR Contact DNA DETERMINES WHAT SOMETHING IS; BETTER DNA DEFINES WHAT IT COULD BE Intrexon's Better DNA approach means realizing better products and proc...

Home Applications Markets Overview Health Food Energy Environment Technology Company Overview Management Team Board of Directors Newsroom Careers IIBR Contact The Intrexon Institute for Biomolecular Research (IIBR) establishes collaborations between not-for-profit institutions and Intrexons market s...

Home Applications Markets Overview Health Food Energy Environment Technology Company Overview Management Team Board of Directors Newsroom Careers IIBR Contact Fibrocell Science and Intrexon Expand Collaboration for Potential New Class of Therapeutics Adds Therapeutic Pipeline for Gene Modified Autol...

Home Applications Markets Overview Health Food Energy Environment Technology Company Overview Management Team Board of Directors Newsroom Careers IIBR Contact ZIOPHARM Oncology Initiates Phase 2 Study of Ad-RTS IL-12 and Palifosfamide Combination for Treatment of Advanced Breast Cancer NEW YORK, NY ...

Home Applications Markets Overview Health Food Energy Environment Technology Company Overview Management Team Board of Directors Newsroom Careers IIBR Contact ZIOPHARM Presents Preclinical Data Supporting DNA-based IL-12 Therapy for Breast Cancer Immunotherapeutic Strategy Results Presented at AACR ...